Lawrence D. Kingsley - 11 May 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Lawrence D. Kingsley
Issuer symbol
IDXX
Transactions as of
11 May 2022
Net transactions value
$0
Form type
4
Filing time
13 May 2022, 17:43:41 UTC
Previous filing
02 May 2022
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +224 +2.9% $0.000000 8,002 11 May 2022 Direct
transaction IDXX Common Stock Options Exercise $0 +78 +0.97% $0.000000 8,080 11 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award +945 945 11 May 2022 Common Stock 945 $333.90 Direct F1, F5
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award +329 +35% 1,274 11 May 2022 Common Stock 329 $333.90 Direct F1, F3, F5
transaction IDXX Restricted Stock Unit Award +344 +114% 646 11 May 2022 Common Stock 344 Direct F2, F5
transaction IDXX Restricted Stock Unit Award +120 +19% 766 11 May 2022 Common Stock 120 Direct F2, F3, F5
transaction IDXX Restricted Stock Unit Options Exercise -224 -29% 542 11 May 2022 Common Stock 224 Direct F4, F5
transaction IDXX Restricted Stock Unit Options Exercise -78 -14% 464 11 May 2022 Common Stock 78 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier.
F2 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier.
F3 Additional grant made pursuant to reporting person's role as Non-Executive Board Chair.
F4 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in in one installment on the one year anniversary of the date of grant or on the date of the 2022 annual meeting of shareholders, whichever event was earlier.
F5 Not applicable.